Neuropsychopharmacology

Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor (J.-C. Schwartz, S. Morisset, A. Rouleau, X. Ligneau, F. Gbahou, J. Tardivel-Lacombe, H. Stark, W. Schunack, C. R. Ganellin and J. M. Arrang) The role of peptides in treatment of psychiatric disorders (F. Holsboer) Pharmacological approaches to migraine (H.-Ch. Diener) Advances in the pharmacological management of Parkinson`s disease (E. Tolosa) Depression and antisocial personality disorder: two contrasting disorders of 5HT function (J. F. W. Deakin) Future directions in substance dependence research (D. Nutt, A. Lingford-Hughes, M. Daglish) New developments in the pharmacotherapy of schizophrenia (W. W. Fleischhacker)